causal
Diminishing returns as risk decreases require bigger trials
As you move down to lower-risk populations and additional doses, the benefit signal shrinks, requiring larger and larger randomized trials to detect it; yet the regulatory system has demanded less and less data as it has moved along to boosters and second boosters.
causalpending
Speaker
Vinay PrasadEvidence Quote
“the way in medicine we typically sort these out is larger and larger randomized trials. You're looking for smaller and smaller signals. You need larger and larger sample size. Though what we found with the regulatory system around vaccines and boosters... is as we've moved along, we've gotten less and less data.”
Created: 6/13/2026, 12:17:03 AM
Your notes
Loading notes...